Healthcare -
Biotechnology - NASDAQ - US
$ 1.6
1.3 %
$ 1.02 B
Market Cap
-7.43
P/E
GERN - CAPITAL EXPENDITURES
Capital Expenditures GERN - Geron Corporation
-680 K
LAST VALUE
-25.61%
2 YEAR CAGR
-10.49%
5 YEAR CAGR
-17.90%
10 YEAR CAGR